Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

NCT06479954 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
1
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer